Job Description
Key responsibilities for this position include, but are not limited to:
- Detailing and selling of products to specialists, supportive care staff, medical aid case managers, private and state hospitals;
- Sales tracking;
- Individual customer potential analysis and developmental plans;
- Customer relationship management;
- Key opinion leader identification and development;
- Presentations to academic groups;
- Arranging of CME’s and small group meetings;
- Continuously updating your knowledge in the disease area of responsibility.
Desired Skills & Experience
The successful candidate should be in possession of:
- B. Pharm/ BSc degree with a sound knowledge of Anatomy and Physiology
- Minimum of 3 years detailing experience in a specialty field.
- Knowledge of Oncology and Renal disease areas will be an added advantage.
The following special skills are key to this role:
- Excellent communication, presentation, negotiation and persuasive selling skills.
- Good interpersonal skills and self motivated with a demonstration of initiative
- Excellent planning and organisational skills
- Ability to use a customer relationship management tool effectively
- Ability to work independently as well as in a team
- Computer Literacy in MS OfficeThe successful candidate must be fluent in English
Company Description
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.
For more information:http://www.roche.com
No comments: